[Embryotoxic and antimitotic properties of parbendazole, mebendazole and cambendazole].
D000014:Abnormalities, Drug-Induced; D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology*; D002159:Cambendazole / Q000494:pharmacology*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D004622:Embryo, Mammalian / Q000187:drug effects; D004625:Embryo, Nonmammalian; D007938:Leukemia / Q000188:drug therapy; D007939:Leukemia L1210 / Q000188:drug therapy; D008463:Mebendazole / Q000494:pharmacology*; D008938:Mitosis / Q000187:drug effects*; D013045:Species Specificity
D001562:Benzimidazoles; D002159:Cambendazole; D008463:Mebendazole
Propriétés embryotoxiques et antimitotiques du parbendazole, du mébendazole et du cambendazole